Nipah Virus: Transmission Dynamics of a Zoonotic Outbreak and Therapeutic Challenges

Nipah virus (NiV) is a deadly zoonotic virus that has caused multiple outbreaks since it was first identified in Malaysia in 1998. It is primarily transmitted by fruit bats and can spread among humans, leading to severe neurological and respiratory complications. With fatality rates ranging from 40% to 75%, NiV poses a serious public health threat, and there are currently no approved treatments or vaccines. The virus enters human cells via ephrin-B2 and ephrin-B3 receptors, causing extensive harm while evading the immune system, which complicates treatment efforts. Environmental changes, including deforestation and increased human–wildlife contact, have heightened the likelihood of NiV outbreaks. Preventing future outbreaks necessitates early detection, strict biosecurity measures, and concerted global efforts to develop antiviral therapies and vaccines. This review comprehensively examines NiV's virology, transmission dynamics, clinical manifestations, and the latest advances in therapeutic care, encompassing One Health strategies and preventive measures.

Authors

Institutions

Publication Details

Journal
Biomedical Research and Therapy
Published
2025-05-31
DOI
https://doi.org/10.15419/bmrat.v12i5.975
Citations
2
Primary Topic
Virology and Viral Diseases
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nipah Virus: Transmission Dynamics of a Zoonotic Outbreak and Therapeutic Challenges

Agnishwar Girigoswami, Koyeli Girigoswami, Venkatakrishnan Kiran
2 citations
Biomedical Research and Therapy
Virology and Viral Diseases
2.71
article

Nipah Virus: Transmission Dynamics of a Zoonotic Outbreak and Therapeutic Challenges

Agnishwar Girigoswami, Koyeli Girigoswami, Venkatakrishnan Kiran
article en
2 citations

Abstract

Nipah virus (NiV) is a deadly zoonotic virus that has caused multiple outbreaks since it was first identified in Malaysia in 1998. It is primarily transmitted by fruit bats and can spread among humans, leading to severe neurological and respiratory complications. With fatality rates ranging from 40% to 75%, NiV poses a serious public health threat, and there are currently no approved treatments or vaccines. The virus enters human cells via ephrin-B2 and ephrin-B3 receptors, causing extensive harm while evading the immune system, which complicates treatment efforts. Environmental changes, including deforestation and increased human–wildlife contact, have heightened the likelihood of NiV outbreaks. Preventing future outbreaks necessitates early detection, strict biosecurity measures, and concerted global efforts to develop antiviral therapies and vaccines. This review comprehensively examines NiV's virology, transmission dynamics, clinical manifestations, and the latest advances in therapeutic care, encompassing One Health strategies and preventive measures.

Biomedical Research and TherapyVol. 12(5)
Chettinad Academy of Research and Education (IN), Saveetha University (IN)
Good health and well-being, Zero hunger
Openalex Percentile: Top 10%
Virology and Viral Diseases
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.